Abstract
Objectives Prevention of fetal growth restriction/small for gestational age is adequate if screening is accurate. Ultrasound and biomarkers can achieve this goal; however, both are often inaccessible. This study aimed to develop, validate, and deploy a prognostic prediction model for screening fetal growth restriction/small for gestational age using only medical history.
Methods From a nationwide health insurance database (n=1,697,452), we retrospectively selected visits of 12-to-55-year-old females to 22,024 healthcare providers of primary, secondary, and tertiary care. This study used machine learning (including deep learning) to develop prediction models using 54 medical-history predictors. After evaluating model calibration, clinical utility, and explainability, we selected the best by discrimination ability. We also externally validated and compared the models with those from previous studies, which were rigorously selected by a systematic review of Pubmed, Scopus, and Web of Science.
Results We selected 169,746 subjects with 507,319 visits for predictive modeling. The best prediction model was a deep-insight visible neural network. It had an area under the receiver operating characteristics curve of 0.742 (95% confidence interval 0.734 to 0.750) and a sensitivity of 49.09% (95% confidence interval 47.60% to 50.58% using a threshold with 95% specificity). The model was competitive against the previous models in a systematic review of 30 eligible studies of 381 records, including those using either ultrasound or biomarker measurements. We deployed a web application to apply the model.
Conclusions Our model used only medical history to improve accessibility for fetal growth restriction/small for gestational age screening. However, future studies are warranted to evaluate if this model’s usage impacts patient outcomes.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://doi.org/10.21203/rs.3.pex-1655/v1
Funding Statement
This study was funded by: (1) the Postdoctoral Accompanies Research Project from the National Science and Technology Council (NSTC) of Taiwan (grant no.: NSTC111-2811-E-038-003-MY2), and the Lembaga Penelitian dan Pengabdian kepada Masyarakat (LPPM) Universitas Nahdlatul Ulama Surabaya of Indonesia (grant no.: 161.4/UNUSA/Adm-LPPM/III/2021) to Herdiantri Sufriyana; and (2) the Ministry of Science and Technology (MOST) of Taiwan (grant nos.: MOST110-2628-E-038-001 and MOST111-2628-E-038-001-MY2), and the Higher Education Sprout Project from the Ministry of Education (MOE) of Taiwan (grant no.: DP2-111-21121-01-A-05) to Emily Chia-Yu Su. These funding bodies had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Taipei Medical University Joint Institutional Review Board exempted this project from the ethical review (TMU-JIRB no.: N202106025). The study used ONLY openly available human data that were originally located at: https://e-ppid.bpjs-kesehatan.go.id/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The social security administrator provided the data for health or badan penyelenggara jaminan sosial (BPJS) kesehatan in Indonesia, with restrictions (access approval no.: 510/PPID/1223). Data are available from the authors upon reasonable request and with permission of the BPJS Kesehatan. The latter needs a request to the BPJS Kesehatan for their sample dataset published in August 2019.
Abbreviations
- AUROC
- area under the receiver operating characteristics curve
- CI
- confidence interval
- DI-VNN
- deep-insight visible neural network
- ENR
- elastic net regression
- FGR
- fetal growth restriction
- GBM
- gradient boosting machine
- ICD-10
- International Classification of Disease version 10
- OR
- odds ratio
- PC
- principal component
- PN
- probability of necessity
- PS
- probability of sufficiency
- RF
- random forest
- ROC
- receiver operating characteristics
- RR
- ridge regression
- SGA
- small for gestational age
